or using other stimuli, i.e. IL-4 and TNF-α, indicating a specific function for the rs3761847 polymorphism in unstimulated and LPS+IFNγ-activated monocytes. Conclusions: Our findings suggest that there is no relationship between invasive capacity of RASF or expression of TRAF1-C5 genes and genotype at rs3761847. In contrast, we report an association of the rs3761847 genotype and TRAF1 expression in monocytes. These data underline the importance of studying genotype-phenotype associations in the different cell types relevant for RA pathogenesis. Objectives: We sought to validate three single nucleotide polymorphisms (SNPs), namely PTPRC (rs10919563), TYK2 (rs34536443) and PRKCQ (rs4750316), previously found to be associated with JIA [2-4], and to investigate whether the 27-bp VNTR polymorphism on intron 4 of eNOS, which is associated with various autoimmune diseases so far [5], is associated with risk for JIA in Greece.
Background: The hallmark of osteoarthritis (OA) is the breakdown of articular cartilage. Articular cartilage is an avascular tissue, and this generates a hypoxic microenvironment. Hypoxia inducible factor-1α (HIF-1α) is the main transcriptional regulator of cellular and developmental response to hypoxia. Objectives: The present study was designed to investigate whether genetic polymorphisms of the HIF-1α signaling pathway are involved in the development of knee OA. Methods: A total of 243 unrelated Mexican-mestizo individuals comprising 93 knee OA patients and 150 healthy controls were recruited into the study. 42 genetic polymorphisms from 22 genes involved in the HIF-1α signaling pathway (PIK3R1, AKT2, GSK3B, IL6, AGER, HIF1A, EGLN1, VHL, HIF1AN, VEGFA, EPO, NOS2, NOS3, IGF1, EGF, EDN1, MMP1, MMP3, MMP13, CA, COL2A1, COL3A1) were genotyped in cases and controls using TaqMan-based allelic discrimination assays. Results: After adjusting for age, sex and admixture, significant associations with knee OA were found for 7 SNPs in the case-control study. The following genotypes and alleles were associated with protection against OA: the CT genotype of the HIF1AN Background: Lupus nephritis (LN) is a severe complication of Systemic Lupus Erythematosus (SLE). Non-invasive biomarkers are needed for diagnosis of LN and to identify patients at risk of a renal flare (1). Thus the presence of biomarkers associated with inflammation, tissue damage or cell activation in the urine of patients with LN may be a useful tool in the evaluation of LN patients. The glomerular filtration rate (GFR) is considered the best overall index of renal function in health and disease. Because GFR is difficult to measure in clinical practice, most clinicians estimate the GFR (eGFR) from the serum creatinine concentration (2). B Lymphocyte Stimulator (BLyS) is a cytokine that fosters B cell activation, antibody production, B cell -T cell interaction and plasma cell survival. These events have been demonstrated to play a role in patients with LN (3). Objectives: We evaluated urinary levels of BLyS as biomarker for LN and their relationship with eGFR.
